60 Biggest Movers From Yesterday
Gainers
Cyngn Inc. (NASDAQ: CYN) shares jumped 96.3% to close at $2.12 on Thursday after the company announced the official launch of DriveMod Kit, a turnkey autonomous vehicle solution.
Windtree Highlights Late-Breaker Presentation On Phase 2 SEISMiC Study Results Of Istaroxine In Early Cardiogenic Shock At European Society Of Cardiology Heart Failure Conference May 22
Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced a late-breaker presentation
The Daily Biotech Pulse: Windtree Jumps On Istaroxime Data, Arcturus’ COVID-19 Vaccine Trial Data, FDA Rejects Teva’s Schizophrenia Med, Otonomy Aces Hearing Loss Study
Here's a roundup of top developments in the biotech space over the last 24 hours.
Windtree Therapeutics Q4 EPS $(0.46) Down From $(0.44) YoY
Windtree Therapeutics (NASDAQ:WINT) reported quarterly losses of $(0.46) per share. This is a 4.55 percent decrease over losses of $(0.44) per share from the same period last year.
Windtree Posts Mid-Stage Study Data On Lucinactant For COVID-19-Associated Respiratory Distress
Windtree Therapeutics Inc (NASDAQ: WINT)
Windtree Therapeutics Concludes Enrollment In Mid-Stage Cardiogenic Shock Study, Data Expected In April
Windtree Therapeutics Inc (NASDAQ: WINT) has
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's trading, 505 companies set new 52-week lows.
Why Are Windtree Therapeutics Shares Trading Higher Today?
Windtree Therapeutics Inc (NASDAQ: WINT) has